Eli Lilly today announced positive top-line results from the Phase III BRUIN CLL-314 clinical trial of Jaypirca ...

ReAlta Life Sciences, a US biopharma seeking to address life-threatening rare and acute inflammatory diseases by rebalancing the inflammatory response, has announced the appointment of Ellen Lubman as ...

Privately-held Italian pharma company Alfasigma has announced positive topline results from the OLINGUITO Phase III trial of ...

Denmark’s diabetes and obesity giant Novo Nordisk saw its shares plummet more than 27% to 328.20 kroner this morning as it ...

Russia is currently experiencing a strong increase in the sales of drugs against alcoholism, as the number of citizens, who ...

US pharma giant Merck & Co was trading 4% lower in pre-market Tuesday after the group presented its second quarter 2025 ...

US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...

California’s MapLight Therapeutics has announced an oversubscribed $372.5 million Series D financing. MapLight's lead program, ML-007C-MA, is an oral fixed-dose combination of the investigational ...

Family-owned Boehringer Ingelheim, now Germany’s largest drugmaker by revenue, has reported positive growth in the first half ...

US biotech PTC Therapeutics’ shares trading up 4.8% to $46.48 in after-hours activity yesterday, as it announced that the US ...

AstraZeneca (LSE: AZN) posted a robust second-quarter 2025 performance, lifted by record growth in its US business and solid ...

The US Food & Drug Administration (FDA) has approved Danish biotech Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd; ...